{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:30:54Z","timestamp":1790483454505,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,13]]},"DOI":"10.7759\/cureus.101437","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:48:37Z","timestamp":1768312117000},"source":"Crossref","is-referenced-by-count":2,"title":["Ischemic Colitis Associated With Tirzepatide Therapy in a Young Female Patient: A Case Report"],"prefix":"10.7759","author":[{"given":"Simone","family":"Sekhon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibaadat","family":"Kahlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Latson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2174\/0118715303319530240703111013","article-title":"A new drug for obesity: tirzepatide","volume":"25","author":"Sidhu JK","year":"2025","unstructured":"Sidhu JK, Singh S. A new drug for obesity: tirzepatide. Endocr Metab Immune Disord Drug Targets. 2025, 25:267-70. 10.2174\/0118715303319530240703111013","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000001551","article-title":"Tirzepatide-associated colonic ischemia","volume":"11","author":"Bayless D","year":"2024","unstructured":"Bayless D, Singh J, Park BU, Sweetser S. Tirzepatide-associated colonic ischemia. ACG Case Rep J. 2024, 11:e01551. 10.14309\/crj.0000000000001551","journal-title":"ACG Case Rep J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.78832","article-title":"Semaglutide-associated ischemic colitis in a patient without traditional risk factors: a case report","volume":"17","author":"Sekhon S","year":"2025","unstructured":"Sekhon S, Bacon J, Kahlon IS. Semaglutide-associated ischemic colitis in a patient without traditional risk factors: a case report. Cureus. 2025, 17:e78832. 10.7759\/cureus.78832","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0000864992.88559.a6","article-title":"Glucagon-like peptide-1 receptor agonist-associated colonic ischemia: a case report","volume":"117","author":"Wichelmann TA","year":"2022","unstructured":"Wichelmann TA, Kruchko DH, Silas D, et al.. Glucagon-like peptide-1 receptor agonist-associated colonic ischemia: a case report. Am J Gastroenterol. 2022, 117:21424. 10.14309\/01.ajg.0000864992.88559.a6","journal-title":"Am J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0001048148.32269.ea","article-title":"S4695 gastrointestinal adverse effects of dual GLP-1 and GIP receptor agonist used for weight loss","volume":"119","author":"Wright J","year":"2024","unstructured":"Wright J, Russell J, Tran J, Tran T. S4695 gastrointestinal adverse effects of dual GLP-1 and GIP receptor agonist used for weight loss. Am J Gastroenterol. 2024, 119:S2970. 10.14309\/01.ajg.0001048148.32269.ea","journal-title":"Am J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1608657","article-title":"A retrospective observational study on case reports of adverse drug reactions (ADRs) to tirzepatide","volume":"16","author":"Huang M","year":"2025","unstructured":"Huang M, Liu G, Zhang C, Wang Y, Liu S, Zhao J. A retrospective observational study on case reports of adverse drug reactions (ADRs) to tirzepatide. Front Pharmacol. 2025, 16:1608657. 10.3389\/fphar.2025.1608657","journal-title":"Front Pharmacol"},{"key":"ref7","unstructured":"Continued treatment with tirzepatide is necessary to maintain weight loss. (2024). Accessed. 2025: https:\/\/gi.org\/journals-publications\/ebgi\/schoenfeld2_feb2024\/."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051128","article-title":"GLP-1R agonists and their therapeutic potential in inflammatory bowel disease and other immune-mediated inflammatory diseases, a systematic review of the literature","volume":"13","author":"Thin L","year":"2025","unstructured":"Thin L, Teh WL. GLP-1R agonists and their therapeutic potential in inflammatory bowel disease and other immune-mediated inflammatory diseases, a systematic review of the literature. Biomedicines. 2025, 13:1128. 10.3390\/biomedicines13051128","journal-title":"Biomedicines"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2024.101805","article-title":"Safety profile of tirzepatide: a real-world pharmacovigilance analysis of the EudraVigilance database","volume":"23","author":"Khurana A","year":"2024","unstructured":"Khurana A, Kumar R, Sharma N, et al.. Safety profile of tirzepatide: a real-world pharmacovigilance analysis of the EudraVigilance database. Clin Epidemiol Glob Health. 2024, 23:101805. 10.1016\/j.cegh.2024.101805","journal-title":"Clin Epidemiol Glob Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100979","article-title":"GLP-1 based therapies and disease course of inflammatory bowel disease","volume":"37","author":"Villumsen M","year":"2021","unstructured":"Villumsen M, Schelde AB, Jimenez-Solem E, Jess T, Allin KH. GLP-1 based therapies and disease course of inflammatory bowel disease. EClinicalMedicine. 2021, 37:100979. 10.1016\/j.eclinm.2021.100979","journal-title":"EClinicalMedicine"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.r1606","article-title":"Side effects of GLP-1 receptor agonists","volume":"390","author":"Manne-Goehler J","year":"2025","unstructured":"Manne-Goehler J, Franco J. Side effects of GLP-1 receptor agonists. BMJ. 2025, 390:r1606. 10.1136\/bmj.r1606","journal-title":"BMJ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/424942-ischemic-colitis-associated-with-tirzepatide-therapy-in-a-young-female-patient-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:48:41Z","timestamp":1768312121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/424942-ischemic-colitis-associated-with-tirzepatide-therapy-in-a-young-female-patient-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.101437","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,13]]}}}